Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/22/2008EP1981845A2 Sulfonamide derivatives to treat infection with hepatitis c virus
10/22/2008EP1981844A1 Novel lactams
10/22/2008EP1981843A2 Vitamin d analog: nel, methods and uses thereof
10/22/2008EP1981842A2 Sulfonamide derivatives, preparation and therapeutic application thereof
10/22/2008EP1981840A1 Process for manufacturing entacapone
10/22/2008EP1981839A1 Non-natural amino acid derivatives
10/22/2008EP1981596A2 Novel compounds
10/22/2008EP1981545A2 Pharmaceutical formulations
10/22/2008EP1981541A2 Methods and compositions of targeted drug development
10/22/2008EP1981523A2 Novel hcv inhibitor combinations and methods
10/22/2008EP1981522A2 Compositions and methods for enhancing neuronal plasticity and regeneration
10/22/2008EP1981513A2 Compositions comprising kakadu plum extract or acai berry extract
10/22/2008EP1981512A1 Modified macromolecule
10/22/2008EP1981511A1 Hemostatic material
10/22/2008EP1981510A1 A pharmaceutical composition comprising oenothein c useful for the treatment of peptic ulcer diseases
10/22/2008EP1981509A1 Treatment of alzheimer's disease and related conditions
10/22/2008EP1981508A2 Potassium channel inhibitors
10/22/2008EP1981507A2 Potassium channel inhibitors
10/22/2008EP1981506A2 Long term treatment of hiv- infection with tcm278
10/22/2008EP1981505A2 Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction
10/22/2008EP1981504A2 Thiadiazole derivatives for the treatment of neuro degenerative diseases
10/22/2008EP1981502A2 Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same
10/22/2008EP1981501A2 Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
10/22/2008EP1981500A1 Pharmaceutical use of 2-hydroxy-3- [5-(morpholin-4-ylmethyl) pyridine-2-yl]-1h- indole-5-carbonitrile as a free base or salts
10/22/2008EP1981499A1 Use of 2-imidazoles for the treatment of cns disorders
10/22/2008EP1981498A2 Use of 2-imidazoles for the treatment of cns disorders
10/22/2008EP1981497A2 Use of substituted 2-imidazole of imidazoline derivatives
10/22/2008EP1981496A1 A pharmaceutical composition comprising perindopril
10/22/2008EP1981495A2 Use of vildagliptin for the treatment of diabetes
10/22/2008EP1981494A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor
10/22/2008EP1981493A1 Acat inhibitors and their use in the prevention or treatment of fibrosis
10/22/2008EP1981492A1 Whitening dermatological preparations
10/22/2008EP1981491A2 Formulations and methods for treating dry eye
10/22/2008EP1981490A1 Long term weight maintenance
10/22/2008EP1981489A2 Inhibition of inflammatory cytokine production with tanshinones
10/22/2008EP1981488A1 Means and methods for the treatment and prevention of allergic diseases
10/22/2008EP1981486A2 Polymeric implant and a process for obtaining a polymeric implant
10/22/2008EP1981485A1 Solid pharmaceutical composition comprising irbesartan
10/22/2008EP1981480A1 Foam-forming composition
10/22/2008EP1981479A1 Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
10/22/2008EP1981478A2 Central administration of stable formulations of therapeutic agents for cns conditions
10/22/2008EP1981477A1 A topical composition comprising an antibacterial substance
10/22/2008EP1981476A2 Pharmaceutical formulations
10/22/2008EP1981475A2 Pharmaceutical formulations
10/22/2008EP1981343A2 Treatment of inflammatory disorders with triazole compounds
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008EP1981337A2 Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof
10/22/2008EP1877411A4 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
10/22/2008EP1856521A4 Modulation of th2 lineage commitment by t-bet
10/22/2008EP1756089B1 Mercaptoimidazoles as ccr2 receptor antagonists
10/22/2008EP1697359B1 Muscarinic agonists as therapeutic compounds
10/22/2008EP1677599A4 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
10/22/2008EP1675573B1 Controlled release sterile injectable aripiprazole formulation and method
10/22/2008EP1667647A4 Monocyclic and bicyclic lactams as factor xa inhibitors
10/22/2008EP1660461B1 Novel condensed n-pyrazinyl-sulphonamides and their use in the treatment of chemokine mediated diseases
10/22/2008EP1658269B1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/22/2008EP1654228B1 Tetrahydrocarbazole derivatives and their pharmaceutical use
10/22/2008EP1654226B1 (2s,4s)-4-fluoro-1- 4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl -2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
10/22/2008EP1648879B1 Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
10/22/2008EP1636228B1 Novel pyridopyrazines and use thereof as kinase modulators
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1596868B1 Method for treating severe heart failure and medicament therefor
10/22/2008EP1594864B1 Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs
10/22/2008EP1583544A4 Method of treatment for central nervous system injury
10/22/2008EP1583542B9 Compositions and methods for combination antiviral therapy
10/22/2008EP1549652B1 Fused azole-pyrimidine derivatives
10/22/2008EP1472257B1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
10/22/2008EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
10/22/2008EP1443945B1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis or chondromalacia
10/22/2008EP1425265B1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
10/22/2008EP1425018B1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
10/22/2008EP1417196B1 Dna-pk inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008EP1408984B1 Organo-phosphorous compounds for activating gamma/delta t cells
10/22/2008EP1404349B1 Fat-binding polymers
10/22/2008EP1370158B1 Method and product for treating cancer in dogs
10/22/2008EP1368371B1 Transfection complexes
10/22/2008EP1365755B1 Use of pyrimidine nucleosides and/or the prodrugs thereof for combating the side-effects of haart (highly active anti-retroviral therapy) and other anti-viral therapies
10/22/2008EP1319009B1 Intermediates in cephalosporin production
10/22/2008EP1318983B1 Substituted imidazoles as histamine h1 and h3 agonists or antagonists
10/22/2008EP1311679B1 Method for inhibiting il-22 induced pap1
10/22/2008EP1307565B1 Vaccins against marek's disease virus (mdv) and varicella zoster virus (vzv)
10/22/2008EP1054677B1 Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
10/22/2008EP0854729B2 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
10/22/2008EP0787011B1 microemulsion preconcentrate comprising a macrolide
10/22/2008EP0549592B2 Stabilized retinoid-containing skin care compositions
10/22/2008CN101292039A Method for producing cercosporamide
10/22/2008CN101292020A A process for the removal of sterols and other compounds from glycerol oils
10/22/2008CN101291950A 新系列咪唑基取代的类固醇和茚满-1-酮衍生物 New series of imidazolyl substituted steroidal and indan-1-one derivative
10/22/2008CN101291949A Aptamers comprising arabinose modified nucleotides
10/22/2008CN101291948A Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
10/22/2008CN101291947A Crystalline forms of macrolide compounds endowed with antiinflammatory activity
10/22/2008CN101291946A Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
10/22/2008CN101291939A Thiazolo[4,5-C]pyridine derivatives as mGluR5 receptor antagonists
10/22/2008CN101291938A Compounds and compositions as protein kinase inhibitors
10/22/2008CN101291936A Fused tricyclic mglur1 antagonists as therapeutic agents
10/22/2008CN101291934A Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
10/22/2008CN101291933A Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
10/22/2008CN101291932A Triazolopyridine derivatives as inhibitors of lipases and phospholipases
10/22/2008CN101291931A 9-azabicyclo [3.3.1]nonane derivatives as monoamine reuptake inhibitors
1 ... 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 ... 7860